425 related articles for article (PubMed ID: 33454875)
1. A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
Song BI
Breast Cancer; 2021 May; 28(3):664-671. PubMed ID: 33454875
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of
Song BI; Kim HW; Won KS
Ann Surg Oncol; 2017 Aug; 24(8):2174-2181. PubMed ID: 28432480
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohistochemistry and inflammatory markers.
Can C; Komek H
Nucl Med Commun; 2019 Oct; 40(10):1051-1059. PubMed ID: 31365497
[TBL] [Abstract][Full Text] [Related]
6. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
Yoo J; Kim BS; Chung J; Yoon HJ
Medicine (Baltimore); 2017 Aug; 96(31):e7657. PubMed ID: 28767583
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
Kim WH; Lee SW; Kim HJ; Chae YS; Jeong SY; Jung JH; Park HY; Lee WK
Sci Rep; 2018 Feb; 8(1):3181. PubMed ID: 29453385
[TBL] [Abstract][Full Text] [Related]
8. Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer.
Tan H; Wu Y; Bao F; Zhou J; Wan J; Tian J; Lin Y; Wang M
Br J Radiol; 2020 Jul; 93(1111):20191019. PubMed ID: 32401540
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of primary tumor parameters using
Yoo J; Kim BS; Yoon HJ
Ann Nucl Med; 2018 Nov; 32(9):642-648. PubMed ID: 30094546
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the axillary lymph-node metastatic burden of breast cancer by
Li Y; Han D; Shen C
BMC Cancer; 2024 Jun; 24(1):704. PubMed ID: 38849770
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
[TBL] [Abstract][Full Text] [Related]
12. Radiomics in cone-beam breast CT for the prediction of axillary lymph node metastasis in breast cancer: a multi-center multi-device study.
Zhu Y; Ma Y; Zhai Z; Liu A; Wang Y; Zhang Y; Li H; Zhao M; Han P; Yin L; He N; Wu Y; Sechopoulos I; Ye Z; Caballo M
Eur Radiol; 2024 Apr; 34(4):2576-2589. PubMed ID: 37782338
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of 18F-FDG PET/CT and ultrasonography in the diagnosis of breast cancer and axillary lymph node metastasis.
He X; Sun L; Huo Y; Shao M; Ma C
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):429-437. PubMed ID: 25823388
[TBL] [Abstract][Full Text] [Related]
14. The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
Choi WH; Yoo IR; O JH; Kim SH; Chung SK
Br J Radiol; 2011 Jul; 84(1003):593-9. PubMed ID: 21081574
[TBL] [Abstract][Full Text] [Related]
15. Discordant results in
Parisse-Di Martino S; Faure C; Mognetti T
Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Keam B; Im SA; Koh Y; Han SW; Oh DY; Cho N; Kim JH; Han W; Kang KW; Moon WK; Kim TY; Park IA; Noh DY; Chung JK; Bang YJ
Breast Cancer; 2013 Apr; 20(2):167-73. PubMed ID: 22311581
[TBL] [Abstract][Full Text] [Related]
17. Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET/CT could predict axillary lymph node metastasis.
An YS; Kang DK; Jung Y; Kim TH
Medicine (Baltimore); 2017 Nov; 96(45):e8557. PubMed ID: 29137072
[TBL] [Abstract][Full Text] [Related]
18. Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer.
Park J; Byun BH; Noh WC; Lee SS; Kim HA; Kim EK; Choi CW; Lim SM
Clin Nucl Med; 2014 Apr; 39(4):e249-53. PubMed ID: 24152622
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of SUV
Diao W; Tian F; Jia Z
Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
